Which Vaccine Stocks Will Make You a Fortune in 2022?
Vaccine stocks paved the road to riches for many since the start of the coronavirus pandemic. For example, Novavax (NASDAQ: NVAX) soared 2,700% in 2020. And vaccine leader Moderna climbed 1,200% over the past two years. These days, some worry the vaccine stock story may be over. But there's still time to get in on innovative vaccine makers. After all, experts predict the coronavirus will stick around even post pandemic. So, we'll need protection. And that means we'll need vaccines.
Of course, it's impossible to predict with 100% certainty which companies will succeed in the vaccine race -- and whether their share prices will skyrocket. But a good look at their programs offers us some clues about which stocks might make you a fortune this year. Here are three to consider.
Image source: Getty Images.
Source Fool.com
